Cancer Research Presented at Naturopathic Oncology Conference
I recently shared research on the role of Modified Citrus Pectin (MCP) as an important nutritional adjunct for supporting long term health at an oncology conference in Arizona.
I recently attended the Oncology Association of Naturopathic Physician's 2012 Convention (OncANP) in Carefree, Arizona, where I presented breakthrough research to over 300 integrative Naturopathic oncologists. My lecture was on Galectin-3 as a new culprit biomarker for cancer and numerous life-threatening diseases. I also shared research on the critical role of Modified Citrus Pectin (MCP) as the foremost Galectin-3 blocker and an important nutritional adjunct for supporting long term health.
OncANP is a naturopathic organization whose members specialize in the treatment of cancer. A major focus of the association is to provide members with advanced training in the rapidly expanding field of naturopathic oncology, in order to improve quality of care and patient outcome.
It’s truly rewarding to share cutting edge research with the medical community, demonstrating Galectin-3’s role as a chronic disease culprit, and Modified Citrus Pectin’s ability to promote health and prevent disease. Modified Citrus Pectin offers a number of remarkable health benefits, which include binding and blocking excess Galectin-3 molecules throughout the body.
Role of Galectin-3 Molecules
By binding to and blocking excess Galectin-3 molecules, Modified Citrus Pectin disables this rogue protein. In this way, Modified Citrus Pectin prevents Galectin-3 from fueling cancer and wreaking havoc throughout the body on cells, tissues and organs.
A new blood test that measures circulating
levels of Galectin-3 as a risk factor in progressive heart failure is now
approved by the FDA and covered by most health insurance. This test can also be
used by practitioners help to determine risks of damage in other organs,
including the liver, lungs, brain, kidneys, and others, as well as risk and
progression of metastatic cancer.
Synergistic Effects of MCP with
Honokiol for Cancer, Antioxidant
and Anxiety Support
The field of integrative cancer care continues to expand with cutting edge research breakthroughs and therapeutic advancements. The groundbreaking data that I shared at the 2012 OncANP event, and during other integrative medical conferences, continues to establish Modified Citrus Pectin as an important adjunct in the prevention and treatment of many serious health conditions, for which current available therapies may be limited at best.
Source: Free Articles from ArticlesFactory.com
ABOUT THE AUTHOR
Dr. Isaac Eliaz, M.D., MS., L.Ac., has been a pioneer in integrative medicine since the early 1980s. He is a respected researcher, innovative product formulator, clinical practitioner, author and lecturer. Dr. Eliaz is widely regarded as the leading expert in the field of Modified Citrus Pectin research and has been using Modified Citrus Pectin in his clinical practice for over 15 years to treat a variety of conditions. For more info, visit www.DrEliaz.org.